Xinjing Wang, Wei Wang, Dan Cao, Binwei Hu, Shuai Zhang, Baiyong Shen. "An investigator-initiated phase I study evaluating the safety, tolerability, and preliminary efficacy of a personalized neoantigen mRNA vaccine (XP-004) combined with PD-1 inhibitor as adjuvant therapy in resected pancreatic cancer patients intolerant to chemotherapy.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.2509